Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NCK2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TMEM179 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TAF11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TTC28 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | IKBKE | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RP11-211G3.2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CXorf56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RP11-542C16.2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SLC22A17 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | TIMM44 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |